株式会社極東書店トップ > 商品一覧 > Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fourth Edition. 4th edition
商品詳細
Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fourth Edition. 4th edition
・ISBN 978-1-4665-7199-0 hard GB£ 345.00
¥109,296.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Smyth Templeton, Nancy (ed.), |
|---|---|
| 出版社 | (CRC Press Inc, US) |
| 出版年月 | 2015 |
| ページ数 | 1338 pp. |
| 言語 | ENG |
| ニュース番号 | <A00-28144> |
解説
The Most Comprehensive, State-of-the-Art Book on Using Gene and Cell Therapy in Clinical Medicine
Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fourth Edition presents extensive background and basic information, state-of-the-art technologies, important achievements, and lingering challenges in the fields of gene and cell therapies. The fourth edition of this bestseller continues to provide the most comprehensive coverage of these fields in one volume. Some chapters have expanded introductions, making the book even more suitable for classroom use. This edition also offers more material on the contributors' research efforts as well as current technologies, disease targets, and clinical applications.
Divided into four sections, the book covers:
- Delivery systems and therapeutic strategies
- Other therapeutic strategies, including technologies that knock down gene expression
- Gene expression, regulation, and detection
- Gene and cell therapies, disease targets, clinical trials, and regulatory issues
Accessible to a broad audience, including students, scientists, physicians, and lay people, this book provides readers with up-to-date, interdisciplinary knowledge and tools to tackle the evolving areas of gene therapy, cell therapy, and tissue engineering. From introductory information to state-of-the-art technologies and concepts, the book helps readers understand vector design and construction, delivery systems, therapeutic strategies, gene expression and detection, disease targets, clinical applications and trials, cell-based therapies, novel imaging systems, gene regulation, and regulatory affairs.